SC 13G | 2021-01-05 | ALEXANDRIA REAL ESTATE EQUITIES, INC. | YUMANITY THERAPEUTICS, INC. | 781,034 | 7.7% | EDGAR |
SC 13D | 2021-01-04 | COLES N ANTHONY | YUMANITY THERAPEUTICS, INC. | 833,175 | 8.2% | EDGAR |
SC 13G | 2021-01-04 | Merck & Co., Inc. | YUMANITY THERAPEUTICS, INC. | 526,999 | 5.2% | EDGAR |
SC 13G | 2021-01-04 | Susan L. Lindquist Family Trust | YUMANITY THERAPEUTICS, INC. | 490,206 | 4.9% | EDGAR |
SC 13G | 2020-11-18 | Ikarian Capital, LLC | PROTEOSTASIS THERAPEUTICS, INC. | 2,650,347 | 5.1% | EDGAR |
SC 13G/A | 2020-02-14 | GREAT POINT PARTNERS LLC | PROTEOSTASIS THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-14 | GREAT POINT PARTNERS LLC | PROTEOSTASIS THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-14 | 1Globe Capital LLC | PROTEOSTASIS THERAPEUTICS, INC. | 4,545,308 | 8.9% | EDGAR |
SC 13G/A | 2020-02-07 | JENNISON ASSOCIATES LLC | PROTEOSTASIS THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-06 | PRUDENTIAL FINANCIAL INC | PROTEOSTASIS THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2020-02-06 | PRUDENTIAL FINANCIAL INC | PROTEOSTASIS THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13D/A | 2019-12-06 | New Enterprise Associates 12, Limited Partnership | PROTEOSTASIS THERAPEUTICS, INC. | - | - | EDGAR |
SC 13G/A | 2019-11-08 | WELLINGTON MANAGEMENT GROUP LLP | PROTEOSTASIS THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2019-07-10 | BlackRock Inc. | PROTEOSTASIS THERAPEUTICS, INC. | 1,571,199 | 3.1% | EDGAR |
SC 13G/A | 2019-03-18 | 1Globe Capital LLC | PROTEOSTASIS THERAPEUTICS, INC. | 4,178,778 | 8.2% | EDGAR |
SC 13G/A | 2019-02-14 | Cormorant Asset Management, LP | PROTEOSTASIS THERAPEUTICS, INC. | 0 | - | EDGAR |
SC 13G/A | 2019-02-14 | GREAT POINT PARTNERS LLC | PROTEOSTASIS THERAPEUTICS, INC. | 3,045,423 | 6.2% | EDGAR |
SC 13G/A | 2019-02-12 | WELLINGTON MANAGEMENT GROUP LLP | PROTEOSTASIS THERAPEUTICS, INC. | 6,231,005 | 12.7% | EDGAR |
SC 13G | 2019-02-08 | BlackRock Inc. | PROTEOSTASIS THERAPEUTICS, INC. | 2,920,723 | 5.9% | EDGAR |
SC 13G/A | 2019-02-05 | Novartis Bioventures Ltd | PROTEOSTASIS THERAPEUTICS, INC. | 1,356,541 | 2.8% | EDGAR |